Cortical Iron Reflects Severity of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 60, Issue 4, 2017, Pages 1533-1545

  Van Duijn, Sara ^a   Bulk, Marjolein ^a,b   Van Duinen, Sjoerd G ^a   Nabuurs, Rob J A ^a,c   Van Buchem, Mark A ^a   Van Der Weerd, Louise ^a   Natté, Remco ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PERCUROS B V   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; iron; magnetic resonance imaging; myelin

Indexed keywords

AMYLOID BETA PROTEIN; FORMALDEHYDE; IRON; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PARAFFIN; TAU PROTEIN; MAPT PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICROGLIA; MIDDLE AGED; MYELINATED NERVE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEX RATIO; VERY ELDERLY; YOUNG ADULT; AMYLOID PLAQUE; FRONTAL LOBE; METABOLISM; MYELIN SHEATH; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; IRON; MALE; MIDDLE AGED; MYELIN SHEATH; PLAQUE, AMYLOID; SEVERITY OF ILLNESS INDEX; TAU PROTEINS; YOUNG ADULT;

EID: 85033587975     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-161143     Document Type: Article

References (65)

1. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
2. Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. J Neuropathol Exp Neurol 68, 1-14.
3. Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 129, 2856-2866.
4. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319.
5. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725.
6. Rowe CC, Villemagne VL (2011) Brain amyloid imaging. J Nucl Med 52, 1733-1740.
7. van Rooden S, Versluis MJ, Liem MK, Milles J, Maier AB, Oleksik AM, Webb AG, van Buchem MA, van der Grond J (2014) Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker. Alzheimers Dement 10, e19-e26.
8. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS (1999) The correlation between phase shifts in gradientecho MR images and regional brain iron concentration. Magn Reson Imaging 17, 1141-1148.
9. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Gröhn OH, Grimm R, Poduslo JF (2004) In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52, 1263-1271.
10. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 25, 10041-10048.
11. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A (2005) Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 53, 607-613.
12. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA (1999) Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 96, 14079-14084.
13. Meadowcroft MD, Connor JR, Smith MB, Yang QX (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 29, 997-1007.
14. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31, 75-83.
15. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA (2005) Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res 30, 201-205.
16. Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol 81, 105-110.
17. LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760, 298-303.
18. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52.
19. Nabuurs RJ, Hegeman I, Natté R, van Duinen SG, van Buchem MA, van der Weerd L, Webb AG (2011) Highfield MRI of single histological slices using an inductively coupled, self-resonant microcoil: Application to ex vivo samples of patients with Alzheimer's disease. NMR Biomed 24, 351-357.
20. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals. Proc Natl Acad Sci U S A 94, 9866-9868.
21. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, Dhenain M (2006) Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 22, 199-208.
22. Meguro R, Asano Y, Odagiri S, Li C, Iwatsuki H, Shoumura K (2007) Nonheme-iron histochemistry for light and electron microscopy: A historical, theoretical and technical review. Arch Histol Cytol 70, 1-19.
23. House MJ, St Pierre TG, Kowdley KV, Montine T, Connor J, Beard J, Berger J, Siddaiah N, Shankland E, Jin LW(2007) Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med 57, 172-180.
24. van Rooden S, Maat-Schieman ML, Nabuurs RJ, van der Weerd L, van Duijn S, van Duinen SG, NattéR, van Buchem MA, van der Grond J (2009) Cerebral amyloidosis: Postmortem detection with human 7. 0-T MR imaging system. Radiology 253, 788-796.
25. van Duijn S, Nabuurs RJ, van Duinen SG, Natté R (2013) Comparison of histological techniques to visualize iron in paraffin-embedded brain tissue of patients with Alzheimer's disease. J Histochem Cytochem 61, 785-792.
26. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3, 41-51.
27. Ramos P, Santos A, Pinto NR, Mendes R, Magalhäes T, Almeida A (2014) Iron levels in the human brain: A post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol 28, 13-17.
28. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H (2008) Staging of neurofibrillary pathology in Alzheimer's disease:Astudy of the BrainNet Europe Consortium. Brain Pathol 18, 484-496.
29. Torsten H, Kurt H, van de Wiel M, Achim Z (2008) Implementing a Class of Permutation Tests: The coin Package. J Stat Softw 28, 1-23.
30. HughesV(2012) Microglia: The constant gardeners. Nature 485, 570-572.
31. Lue LF, Kuo YM, Beach T, Walker DG (2010) Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol 41, 115-128.
32. Carpenter AF, Carpenter PW, Markesbery WR (1993) Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 52, 601-608.
33. KreutzbergGW(1996) Microglia:Asensor for pathological events in the CNS. Trends Neurosci 19, 312-318.
34. Roschzttardtz H, Conéjéro G, Curie C, Mari S (2009) Identification of the endodermal vacuole as the iron storage compartment in the Arabidopsis embryo. Plant Physiol 151, 1329-1338.
35. Leskovjan AC, Lanzirotti A, Miller LM (2009) Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage 47, 1215-1220.
36. Meadowcroft MD, Connor JR, Yang QX (2015) Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1-E9 mice: A histological perspective. Front Neurosci 9, 255.
37. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J (2006) Synchrotron-based infrared and Xray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 155, 30-37.
38. Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI (2014) The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue. J Anal At Spectrom 29, 565-570.
39. Tao Y, Wang Y, Rogers JT, Wang F (2014) Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: A systematic review and meta-analysis. J Alzheimers Dis 42, 679-690.
40. Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA (2016) Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex. Neuroimage 137, 124-131.
41. Crawford AH, Chambers C, Franklin RJ (2013) Remyelination: The true regeneration of the central nervous system. J Comp Pathol 149, 242-254.
42. Gudi V, Gingele S, Skripuletz T, Stangel M (2014) Glial response during cuprizone-induced de-and remyelination in the CNS: Lessons learned. Front Cell Neurosci 8, 73.
43. Nave KA (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci 11, 275-283.
44. Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9, 839-855.
45. Behrendt G, Baer K, Buffo A, Curtis MA, Faull RL, Rees MI, Gotz M, Dimou L (2013) Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61, 273-286.
46. Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17, 83-93.
47. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: The role of iron. Glia 57, 467-478.
48. Miron VE, Franklin RJ (2014) Macrophages and CNS remyelination. J Neurochem 130, 165-171.
49. Schonberg DL, Goldstein EZ, Sahinkaya FR, Wei P, Popovich PG, McTigue DM (2012) Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 32, 5374-5384.
50. Schonberg DL, McTigue DM (2009) Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol 218, 64-74.
51. Cherry JD, Olschowka JA, O'Banion MK (2014) Neuroinflammation and M2 microglia: The good, the bad, and the inflamed. J Neuroinflammation 11, 98.
52. Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, Campanella A, Brunelli S, Manfredi AA, Apostoli P, Silvestri L, Camaschella C, Rovere-Querini P (2010) Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95, 1814-1822.
53. Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S (2014) TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83, 1098-1116.
54. Teller S, Tahirbegi IB, Mir M, Samitier J, Soriano J (2015) Magnetite-Amyloid-deteriorates activity and functional organization in an in vitro model for Alzheimer's disease. Sci Rep 5, 17261.
55. van Bergen JM, Li X, Hua J, Schreiner SJ, Steininger SC, Quevenco FC, Wyss M, Gietl AF, Treyer V, Leh SE, Buck F, Nitsch RM, Pruessmann KP, van Zijl PC, Hock C, Unschuld PG (2016) Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment. Sci Rep 6, 35514.
56. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873.
57. Silvestri L, Pagani A, CamaschellaC(2008) Furin-mediated release of soluble hemojuvelin:Anewlink between hypoxia and iron homeostasis. Blood 111, 924-931.
58. Ayton S, Faux NG, Bush AI; Alzheimer's Disease Neuroimaging Initiative (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun 6, 6760.
59. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13, 1045-1060.
60. Maher BA, Ahmed IA, Karloukovski V, MacLaren DA, Foulds PG, Allsop D, Mann DM, Torres-Jardon R, Calderon-Garciduenas L (2016) Magnetite pollution nanoparticles in the human brain. Proc Natl Acad Sci U S A 113, 10797-10801.
61. Kumar P, Bulk M, Webb A, van der Weerd L, Oosterkamp TH, Huber M, Bossoni L (2016) A novel approach to quantify different iron forms in ex-vivo human brain tissue. Sci Rep 6, 38916.
62. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J Neurochem 65, 717-724.
63. Ali-Rahmani F, Schengrund CL, Connor JR (2014) HFE gene variants, iron, and lipids: A novel connection in Alzheimer's disease. Front Pharmacol 5, 165.
64. Fukunaga M, Li TQ, van Gelderen P, de Zwart JA, Shmueli K, Yao B, Lee J, Maric D, Aronova MA, Zhang G, Leapman RD, Schenck JF, Merkle H, Duyn JH (2010) Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A 107, 3834-3839.
65. Zeineh MM, Chen Y, Kitzler HH, Hammond R, Vogel H, Rutt BK (2015) Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging 36, 2483-2500.